Login

Unaudited Condensed Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q2 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Sep 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Related party receivable
Prepaid expenses
TOTAL CURRENT ASSETS
Cash and cash equivalents
Related party - Sponsor
Prepaid expenses
Cash and cash equivalents held in Trust Account
TOTAL ASSETS
Accrued expenses
Deferred underwriting compensation
LIABILITIES-
Other payables and accrued expenses
Related party – Sponsor
Deferred underwriting compensation
Amount payable to 2,371,801 Class A ordinary shares following redemption
TOTAL LIABILITIES
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION: 1,864,987 shares at March 31, 2024 and December 31, 2023, at a redemption value of $11.09 and $10.96 per share, respectively
Class A Ordinary Shares
Total cLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION: 1,864,987 shares at March 31, 2024 and December 31, 2023, at a redemption value of $11.09 and $10.96 per share, respectively
CAPITAL DEFICIENCY:
Accumulated deficit
TOTAL CAPITAL DEFICIENCY
TOTAL LIABILITIES AND SHARES SUBJECT TO POSSIBLE REDEMPTION NET OF CAPITAL DEFICIENCY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support